# Platform for Exceptional Genomic Cancer Cases

**PPEGC: Transforming rare clinical observations into scientific insights**

---

## Welcome

The Platform for Exceptional Genomic Cancer Cases (PPEGC) is an international collaborative platform dedicated to sharing exceptional oncological cases associated with genomic alterations. We collect and curate rare cases showing unexpected therapeutic responses, unusual resistance patterns, or atypical toxicities.

Our mission is to identify weak signals in precision oncology, generate biological hypotheses, and facilitate international clinical networking.

---

## Quick Links

### ğŸ“˜ Documentation
- [Governance](GOVERNANCE.md) â€” Platform structure, curation process, and ethical framework
- [Privacy Policy](PRIVACY.md) â€” How we protect patient data (GDPR compliant)
- [Terms of Submission](TERMS.md) â€” Contributor guidelines and clickwrap agreement
- [Patient Information](PATIENT-INFO.md) â€” Information for patients about data sharing

### ğŸš€ Get Started
- **Submit a Case:** [Access REDCap Form](https://redcap.link/20lidode) *(replace with your actual link)*
- **Browse Cases:** [Explore Published Cases](https://ppegc.org/cases) *(coming soon)*
- **Contact Us:** support@ppegc.org

---

## Why PPEGC?

### For Clinicians
- **Share exceptional cases** that could advance precision oncology
- **Gain recognition** with your name and institution credited
- **Network internationally** with experts facing similar cases
- **Contribute to science** while maintaining patient privacy

### For Researchers
- **Access unique data** not available in conventional databases
- **Generate hypotheses** from real-world exceptional responders
- **Identify biomarkers** linked to unexpected clinical outcomes
- **Free and open** under Creative Commons CC BY 4.0 license

### For Patients
- **Your case helps others** by advancing cancer treatment knowledge
- **Privacy protected** through rigorous pseudonymization
- **Voluntary participation** with right to object at any time
- **No impact on care** â€” objection does not affect treatment quality

---

## Key Features

âœ… **Rapid Curation:** Cases reviewed within 7-15 business days  
âœ… **GDPR Compliant:** HDS-certified hosting at Gustave Roussy (France, EU)  
âœ… **Open Science:** Published cases freely accessible under CC BY 4.0  
âœ… **Quality Assured:** Manual curation by expert oncologists and bioinformaticians  
âœ… **Citeable:** Each case receives a DOI for academic citation  
âœ… **International:** Accepting submissions from all countries  

---

## Case Examples *(Placeholder)*

### Featured Cases

**Case #2026-0042: EGFR T790M with unexpected osimertinib hypersensitivity**  
*Lung adenocarcinoma, Stage IV, Female 65-70 years*  
Complete response within 4 weeks but severe skin toxicity (Grade 4). Novel EGFR variant co-occurring with CYP2D6 poor metabolizer status.

**Case #2026-0038: BRAF V600E melanoma with paradoxical progression**  
*Metastatic melanoma, Male 55-60 years*  
Progressive disease on vemurafenib despite confirmed V600E mutation. Molecular profiling revealed concurrent PTEN loss and novel NRAS mutation.

[View All Cases â†’](https://ppegc.org/cases)

---

## Statistics *(Update regularly)*

ğŸ“Š **Cases Submitted:** 127  
âœ… **Cases Published:** 89  
ğŸŒ **Contributing Centers:** 23  
ğŸ—ºï¸ **Countries Represented:** 12  
ğŸ“ˆ **Last Updated:** February 15, 2026  

---

## Partners and Supporters

- **Gustave Roussy Institute** â€” Host institution and infrastructure support
- *[Add partner logos and names as you acquire them]*

---

## Stay Updated

ğŸ“§ **Newsletter:** Subscribe for monthly updates on new cases and research findings  
ğŸ¦ **Twitter/X:** [@PPEGC_Platform](https://twitter.com/ppegc_platform) *(example)*  
ğŸ“° **Blog:** Latest news and impact stories *(coming soon)*  

---

## Contact

**General Inquiries:** contact@ppegc.org  
**Technical Support:** support@ppegc.org  
**Data Protection Officer:** dpo@gustaveroussy.fr  
**Media & Press:** press@ppegc.org  

**Mailing Address:**  
PPEGC Platform  
Gustave Roussy Institute  
114 rue Ã‰douard Vaillant  
94805 Villejuif, France  

---

## Acknowledgments

PPEGC is hosted at Gustave Roussy. We thank all contributing clinicians and researchers for their dedication to advancing precision oncology.

---

*Last updated: February 15, 2026*  
*Website: [semdogan.github.io/ppegc-docs](https://semdogan.github.io/ppegc-docs)*  
*Â© 2026 PPEGC. Content licensed under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).*
